• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夜间血液透析与终末期肾病中受损的内皮祖细胞生物学功能的恢复相关。

Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease.

作者信息

Chan Christopher T, Li Shu Hong, Verma Subodh

机构信息

Toronto General Hosptal, 200 Elizabeth St., 8N-842, Toronto, Ontario, Canada.

出版信息

Am J Physiol Renal Physiol. 2005 Oct;289(4):F679-84. doi: 10.1152/ajprenal.00127.2005. Epub 2005 May 31.

DOI:10.1152/ajprenal.00127.2005
PMID:15928211
Abstract

Cardiovascular disease is the principal cause of death in end-stage renal disease (ESRD) patients. Endothelial progenitor cells (EPCs) play a critical role in vascular repair, and improving EPC biology represents a novel therapeutic target. Three groups of age- and gender-matched patients were studied: 1) 10 healthy control, 2) 12 conventional hemodialysis (CHD) patients, and 3) 10 nocturnal hemodialysis (NHD) patients. EPC number and migratory function were assessed. Left ventricular mass index (LVMI) was derived, and correlations between EPC biology, uremic clearance, and LVMI were made. Compared with controls, EPC number and function were markedly impaired in CHD patients [(3.48 +/- 1.2 vs. 0.86 +/- 0.20%/50,000 cells, P < 0.05) and (18.8 +/- 2.64 vs. 3.75 +/- 0.34 cells/high-power field, P < 0.05), respectively]. In contrast, EPC number and function were normal in NHD patients [(3.48 +/- 1.17 vs. 3.83 +/- 0.77%/50,000 cells) and (18.8 +/- 2.6 vs. 22.2 +/- 2.4 cells/high-power field), respectively]. Among ESRD patients, EPC number and function inversely correlated with predialysis urea concentration (r = -0.40; r = -0.57), LVMI (r = -0.41; -0.46) and systolic BP (r = -0.58; r = -0.44). We demonstrate that NHD is associated with restoration of abnormal EPC biology in ESRD. Given the increasing importance of EPCs in the repair and restoration of cardiovascular function, these data have important clinical implications for vascular risk in ESRD patients.

摘要

心血管疾病是终末期肾病(ESRD)患者的主要死因。内皮祖细胞(EPCs)在血管修复中起关键作用,改善EPC生物学特性是一个新的治疗靶点。研究了三组年龄和性别匹配的患者:1)10名健康对照者,2)12名常规血液透析(CHD)患者,3)10名夜间血液透析(NHD)患者。评估了EPC数量和迁移功能。计算左心室质量指数(LVMI),并分析EPC生物学特性、尿毒症清除率和LVMI之间的相关性。与对照组相比,CHD患者的EPC数量和功能明显受损[分别为(3.48±1.2对0.86±0.20%/50,000细胞,P<0.05)和(18.8±2.64对3.75±0.34细胞/高倍视野,P<0.05)]。相比之下,NHD患者的EPC数量和功能正常[分别为(3.48±1.17对3.83±0.77%/50,000细胞)和(18.8±2.6对22.2±2.4细胞/高倍视野)]。在ESRD患者中,EPC数量和功能与透析前尿素浓度(r=-0.40;r=-0.57)、LVMI(r=-0.41;-0.46)和收缩压(r=-0.58;r=-0.44)呈负相关。我们证明,NHD与ESRD患者异常EPC生物学特性的恢复有关。鉴于EPCs在心血管功能修复和恢复中的重要性日益增加,这些数据对ESRD患者的血管风险具有重要的临床意义。

相似文献

1
Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease.夜间血液透析与终末期肾病中受损的内皮祖细胞生物学功能的恢复相关。
Am J Physiol Renal Physiol. 2005 Oct;289(4):F679-84. doi: 10.1152/ajprenal.00127.2005. Epub 2005 May 31.
2
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells.终末期肾病导致内皮祖细胞和平滑肌祖细胞之间失衡。
Am J Physiol Renal Physiol. 2007 Apr;292(4):F1132-40. doi: 10.1152/ajprenal.00163.2006. Epub 2007 Jan 2.
3
Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure.慢性肾衰竭患者内皮祖细胞数量减少及血管生成功能受损。
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1246-52. doi: 10.1161/01.ATV.0000133488.56221.4a. Epub 2004 May 20.
4
Molecular evaluation of circulating endothelial progenitor cells in children undergoing hemodialysis and after kidney transplantation.接受血液透析的儿童及肾移植术后儿童循环内皮祖细胞的分子评估
Pediatr Res. 2009 Feb;65(2):221-5. doi: 10.1203/PDR.0b013e3181903909.
5
Progenitor cells and vascular function are impaired in patients with chronic kidney disease.慢性肾脏病患者的祖细胞和血管功能受损。
Nephrol Dial Transplant. 2010 Jun;25(6):1875-82. doi: 10.1093/ndt/gfp749. Epub 2010 Jan 18.
6
Impact of augmenting dialysis frequency and duration on cardiovascular function.增加透析频率和时长对心血管功能的影响。
ASAIO J. 2006 Nov-Dec;52(6):e11-4. doi: 10.1097/01.mat.0000249504.07371.5e.
7
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients.血液透析患者的运动能力与循环内皮祖细胞
Int J Sports Med. 2007 May;28(5):368-73. doi: 10.1055/s-2006-924363. Epub 2006 Oct 6.
8
Reduced endothelial progenitor cells in children with hemodialysis but not predialysis chronic kidney disease.血液透析患儿内皮祖细胞减少,但慢性肾脏病未透析患儿无此变化。
Pediatrics. 2010 Oct;126(4):e990-3. doi: 10.1542/peds.2009-3346. Epub 2010 Sep 6.
9
Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients.血液透析患者循环内皮祖细胞数量低的预测因素。
Nephrol Dial Transplant. 2008 Aug;23(8):2611-8. doi: 10.1093/ndt/gfn103. Epub 2008 Mar 19.
10
Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head.股骨头缺血性坏死患者循环内皮祖细胞数量和功能减少。
Bone. 2010 Jan;46(1):32-40. doi: 10.1016/j.bone.2009.09.001. Epub 2009 Sep 10.

引用本文的文献

1
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
2
Challenges and opportunities for stem cell therapy in patients with chronic kidney disease.慢性肾病患者干细胞治疗面临的挑战与机遇
Kidney Int. 2016 Apr;89(4):767-78. doi: 10.1016/j.kint.2015.11.023. Epub 2016 Jan 26.
3
Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.
骨髓细胞分泌产物重复治疗对实验性慢性肾病具有长期肾脏保护作用:一项安慰剂对照试验
Can J Kidney Health Dis. 2015 Nov 14;2:44. doi: 10.1186/s40697-015-0082-5. eCollection 2015.
4
Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study.早期生长的促血管生成细胞数量和功能与常规血液透析患者的左心室结构和功能不相关:一项横断面研究。
Can J Kidney Health Dis. 2015 Jul 30;2:25. doi: 10.1186/s40697-015-0060-y. eCollection 2015.
5
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.将慢性肾病供体大鼠的骨髓进行体外普伐他汀暴露,可减轻慢性肾病受体大鼠的肾损伤。
Stem Cell Res Ther. 2015 Apr 15;6(1):63. doi: 10.1186/s13287-015-0064-7.
6
Bridging the gap: a Canadian perspective on translational kidney research.缩小差距:加拿大对转化性肾脏研究的看法
Can J Kidney Health Dis. 2014 Aug 29;1:18. doi: 10.1186/s40697-014-0018-5. eCollection 2014.
7
Bone marrow cell therapies for endothelial repair and their relevance to kidney disease.骨髓细胞疗法治疗内皮细胞损伤及其与肾脏病的相关性。
Semin Nephrol. 2012 Mar;32(2):215-23. doi: 10.1016/j.semnephrol.2012.02.008.
8
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.强化血液透析与常规血液透析相比可提高生存率。
J Am Soc Nephrol. 2012 Apr;23(4):696-705. doi: 10.1681/ASN.2011070676. Epub 2012 Feb 23.
9
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study.心脏和血管结构与功能参数在夜间交替家庭血液透析中并未改善:一项干预性队列研究。
BMC Nephrol. 2011 Oct 3;12:51. doi: 10.1186/1471-2369-12-51.
10
Hemodialysis in children with end-stage renal disease.儿童终末期肾病的血液透析。
Nat Rev Nephrol. 2011 Sep 6;7(11):650-8. doi: 10.1038/nrneph.2011.124.